Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Biology of the Cell|April 10, 2009
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulationBrigitte Lankat-Buttgereit, Rüdiger GökeBiology of the Cell|November 25, 2003
Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?Brigitte Lankat-Buttgereit, Rüdiger GökeDiabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 20, 2014
Real-life effectiveness and tolerability of vildagliptin and other oral glucose-lowering therapies in patients with type 2 diabetes in GermanyRüdiger Göke, Giovanni Bader, Markus DworakDiabetes & Metabolic Syndrome|December 18, 2016
Addition of once daily prandial lixisenatide to basal insulin therapy in patients with type-2 diabetes results in a reduction of HbA1c as an effect of postprandial glucose loweringHolger Fleischmann, Rüdiger Göke, Peter BramlageApoptosis : an International Journal on Programmed Cell Death|April 26, 2008
The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosisLilian Sewing, Florian Steinberg, Harald Schmidt, et al.The Biochemical Journal|March 7, 2002
Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent mannersSebastian Fehlberg, Stefan Trautwein, Alexandra Göke, et al.Apoptosis : an International Journal on Programmed Cell Death|October 24, 2007
The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cellsBrigitte Lankat-Buttgereit, Barbara Lenschen, Harald Schmidt, et al.British Journal of Pharmacology|June 6, 2003
Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLOSebastian Fehlberg, Cornelia M Gregel, Alexandra Göke, et al.Anticancer Research|October 28, 2015
The FGFR Inhibitor NVP-BGJ398 Induces NSCLC Cell Death by Activating Caspase-dependent Pathways as well as Caspase-independent ApoptosisAntonia Göke, Rüdiger Göke, Andrea Ofner, et al.Annals of the New York Academy of Sciences|May 22, 2004
Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cellsRüdiger Göke, Cornelia Gregel, Alexandra Göke, et al.Pageof 2